These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 26470498)
21. US campaign tackles drug company influence over doctors. McCarthy M Lancet; 2007 Mar; 369(9563):730. PubMed ID: 17340680 [No Abstract] [Full Text] [Related]
22. Industry-to-physician marketing and the cost of prescription drugs. Chiong W Am J Bioeth; 2003; 3(3):W28-W29. PubMed ID: 14594480 [No Abstract] [Full Text] [Related]
23. Small gifts, conflicts of interest, and the zero-tolerance threshold in medicine. Krimsky S Am J Bioeth; 2003; 3(3):50-2. PubMed ID: 14594492 [No Abstract] [Full Text] [Related]
24. The death of common sense. Trachtman H Am J Bioeth; 2003; 3(3):W31-W32. PubMed ID: 14594484 [No Abstract] [Full Text] [Related]
25. These two make quite a team. Kassirer JP Washington Post; 2004 Oct; ():B1, B5. PubMed ID: 15700368 [No Abstract] [Full Text] [Related]
26. Commentary: Epidemiology and the pharmaceutical industry: an inside perspective. Haas J Int J Epidemiol; 2008 Feb; 37(1):53-5; discussion 65-8. PubMed ID: 18184672 [No Abstract] [Full Text] [Related]
27. A Doctrine in Name Only - Strengthening Prohibitions against the Corporate Practice of Medicine. Zhu JM; Rooke-Ley H; Fuse Brown E N Engl J Med; 2023 Sep; 389(11):965-968. PubMed ID: 37694885 [No Abstract] [Full Text] [Related]
28. Should a medical practice accept a gift with strings attached? Agrawal M; Steinberg D Med Ethics (Burlingt Mass); 2001; ():3, 7. PubMed ID: 15584189 [No Abstract] [Full Text] [Related]
29. American academy of pain medicine ethics council statement on conflicts of interest: interaction between physicians and industry in pain medicine. Dubois MY; Pain Med; 2010 Feb; 11(2):257-62. PubMed ID: 19930112 [TBL] [Abstract][Full Text] [Related]
30. From clinic to conference room. Speech-language pathology in the corporate sector. Schwartz K ASHA; 1995; 37(6-7):43-6. PubMed ID: 7598752 [No Abstract] [Full Text] [Related]
32. Corporate funding and conflicts of interest: a primer for psychologists. Pachter WS; Fox RE; Zimbardo P; Antonuccio DO Am Psychol; 2007 Dec; 62(9):1005-15. PubMed ID: 18085846 [TBL] [Abstract][Full Text] [Related]
33. Pharmaceutical industry influences on physician prescribing: gifts, quasi-gifts, and patient-directed gifts. Berger JT Am J Bioeth; 2003; 3(3):56-7. PubMed ID: 14594495 [No Abstract] [Full Text] [Related]
34. The physician and the pharmaceutical industry: both must keep the patient's interests at heart. Ravindran GD Issues Med Ethics; 1999; 7(1):21-2. PubMed ID: 16320467 [No Abstract] [Full Text] [Related]
35. All rationalizations large and small. Goodman B Am J Bioeth; 2003; 3(3):57-8. PubMed ID: 14594496 [No Abstract] [Full Text] [Related]
36. Don't just blame big pharma. Spence D BMJ; 2012 Jul; 345():e4825. PubMed ID: 22807079 [No Abstract] [Full Text] [Related]
37. The Corporate Practice of Medicine: Ethical Implications of Orthopaedic Surgery Practice Ownership by Non-Physicians. Moses MJ; Weiser LG; Bosco JA J Bone Joint Surg Am; 2020 Jun; 102(11):e53. PubMed ID: 32496745 [TBL] [Abstract][Full Text] [Related]
38. Disease mongering in psychiatry: fact or fiction? Saddichha S JNMA J Nepal Med Assoc; 2010; 50(180):320-7. PubMed ID: 22049901 [TBL] [Abstract][Full Text] [Related]
39. Common and conflicting interests in the engagements between conservation organizations and corporations. Robinson JG Conserv Biol; 2012 Dec; 26(6):967-77. PubMed ID: 22900529 [TBL] [Abstract][Full Text] [Related]
40. Rosiglitazone, marketing, and medical science. Moynihan R BMJ; 2010 Apr; 340():c1848. PubMed ID: 20375091 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]